Gary Charles Robb Corcept Therapeutics Inc (CORT) insider trading activity

CORT Quotes by TradingView

Gary Charles Robb is Chief Business Officer of CORCEPT THERAPEUTICS INC. Currently has a direct ownership of 16,549 shares of CORT, which is worth approximately $1.17 Million. The most recent transaction as insider was on Jun 03, 2025, when has been sold 651 shares (Common Stock) at a price of $71.68 per share, resulting in proceeds of $46,663. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.5K
12.28% 3M change
42.82% 12M change
Total Value Held $1.17 Million

Gary Charles Robb Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2025
SELL
Payment of exercise price or tax liability
$46,663 $71.68 p/Share
651 Reduced 3.78%
16,549 Common Stock
Jun 02 2025
BUY
Grant, award, or other acquisition
$71,464 $35.84 p/Share
1,994 Added 10.39%
17,200 Common Stock
May 20 2025
SELL
Open market or private sale
$172,862 $75.85 p/Share
2,279 Reduced 12.08%
16,586 Common Stock
May 20 2025
SELL
Bona fide gift
-
1,380 Reduced 8.32%
15,206 Common Stock
Mar 12 2025
SELL
Bona fide gift
-
4,625 Reduced 19.69%
18,865 Common Stock
Mar 03 2025
SELL
Payment of exercise price or tax liability
$15,145 $60.58 p/Share
250 Reduced 1.08%
22,906 Common Stock
Mar 03 2025
BUY
Grant, award, or other acquisition
$17,251 $29.54 p/Share
584 Added 2.43%
23,490 Common Stock
Jan 03 2025
BUY
Exercise of conversion of derivative security
$9,991 $3.29 p/Share
3,037 Added 11.59%
23,156 Common Stock
Jan 02 2025
SELL
Open market or private sale
$555,500 $50.5 p/Share
11,000 Reduced 35.35%
20,119 Common Stock
Jan 02 2025
BUY
Exercise of conversion of derivative security
$36,190 $3.29 p/Share
11,000 Added 26.12%
31,119 Common Stock
Dec 02 2024
SELL
Payment of exercise price or tax liability
$18,688 $57.68 p/Share
324 Reduced 1.63%
19,539 Common Stock
Dec 02 2024
BUY
Grant, award, or other acquisition
$17,173 $29.61 p/Share
580 Added 2.8%
20,119 Common Stock
Nov 22 2024
SELL
Bona fide gift
-
300 Reduced 1.49%
19,863 Common Stock
Nov 22 2024
SELL
Open market or private sale
$146,625 $56.2 p/Share
2,609 Reduced 11.46%
20,163 Common Stock
Oct 01 2024
SELL
Open market or private sale
$509,080 $46.28 p/Share
11,000 Reduced 32.57%
22,772 Common Stock
Oct 01 2024
BUY
Exercise of conversion of derivative security
$36,190 $3.29 p/Share
11,000 Added 24.57%
33,772 Common Stock
Sep 18 2024
SELL
Bona fide gift
-
870 Reduced 3.68%
22,772 Common Stock
Sep 17 2024
SELL
Bona fide gift
-
300 Reduced 1.25%
23,642 Common Stock
Sep 03 2024
SELL
Payment of exercise price or tax liability
$8,966 $35.3 p/Share
254 Reduced 1.1%
22,936 Common Stock
Sep 03 2024
BUY
Grant, award, or other acquisition
$17,232 $17.13 p/Share
1,006 Added 4.03%
23,942 Common Stock
Aug 26 2024
SELL
Open market or private sale
$110,736 $35.71 p/Share
3,101 Reduced 11.79%
23,190 Common Stock
Jul 01 2024
SELL
Open market or private sale
$357,390 $32.49 p/Share
11,000 Reduced 29.5%
26,291 Common Stock
Jul 01 2024
BUY
Exercise of conversion of derivative security
$36,190 $3.29 p/Share
11,000 Added 22.78%
37,291 Common Stock
Jun 24 2024
SELL
Bona fide gift
-
2,650 Reduced 9.16%
26,291 Common Stock
Jun 04 2024
SELL
Payment of exercise price or tax liability
$268,679 $32.87 p/Share
8,174 Reduced 22.02%
28,941 Common Stock
GCR

Gary Charles Robb

Chief Business Officer
Menlo Park, CA

Track Institutional and Insider Activities on CORT

Follow CORCEPT THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CORT shares.

Notify only if

Insider Trading

Get notified when an Corcept Therapeutics Inc insider buys or sells CORT shares.

Notify only if

News

Receive news related to CORCEPT THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CORT